MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saxena, A.
Right arrow Articles by Doctor, B. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saxena, A.
Right arrow Articles by Doctor, B. P.

Vol. 53, Issue 1, 112-122, January 1998

Role of Oligosaccharides in the Pharmacokinetics of Tissue-Derived and Genetically Engineered Cholinesterases

Ashima Saxena, Yacov Ashani, Lily Raveh, David Stevenson, Thakor Patel and B. P. Doctor

Division of Biochemistry, Walter Reed Army Institute of Research, Washington D. C. 20307-5100 (A.S., B.P.D.), Israel Institute for Biological Research, Ness-Ziona, Israel (Y.A., L.R.), and Oxford GlycoSciences Ltd., Abingdon, Oxon OX14 3YS, UK (D.S., T.P.)

To understand the role of glycosylation in the circulation of cholinesterases, we compared the mean residence time of five tissue-derived and two recombinant cholinesterases (injected intravenously in mice) with their oligosaccharide profiles. Monosaccharide composition analysis revealed differences in the total carbohydrate, galactose, and sialic acid contents. The molar ratio of sialic acid to galactose residues on tetrameric human serum butyrylcholinesterase, recombinant human butyrylcholinesterase, and recombinant mouse acetylcholinesterase was found to be ~1.0. For Torpedo californica acetylcholinesterase, monomeric and tetrameric fetal bovine serum acetylcholinesterase, and equine serum butyrylcholinesterase, this ratio was ~0.5. However, the circulatory stability of cholinesterases could not be correlated with the sialic acid-to-galactose ratio. Fractionation of the total pool of oligosaccharides obtained after neuraminidase digestion revealed one major oligosaccharide for human serum butyrylcholinesterase and three or four major oligosaccharides in other cholinesterases. The glycans of tetrameric forms of plasma cholinesterases (human serum butyrylcholinesterase, fetal bovine serum acetylcholinesterase, and equine serum butyrylcholinesterase) clearly demonstrated a reduced heterogeneity and higher maturity compared with glycans of monomeric fetal bovine serum acetylcholinesterase, dimeric tissue-derived T. californica acetylcholinesterase, and recombinant cholinesterases. T. californica acetylcholinesterase, recombinant cholinesterases, and monomeric fetal bovine serum acetylcholinesterase showed a distinctive shorter mean residence time (44-304 min) compared with tetrameric forms of plasma cholinesterases (1902-3206 min). Differences in the pharmacokinetic parameters of cholinesterases seem to be due to the combined effect of the molecular weight and charge- and size-based heterogeneity in glycans.

Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
O. Cohen, C. Kronman, A. Lazar, B. Velan, and A. Shafferman
Controlled Concealment of Exposed Clearance and Immunogenic Domains by Site-specific Polyethylene Glycol Attachment to Acetylcholinesterase Hypolysine Mutants
J. Biol. Chem., December 7, 2007; 282(49): 35491 - 35501.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
T. Evron, B. C. Geyer, I. Cherni, M. Muralidharan, J. Kilbourne, S. P. Fletcher, H. Soreq, and T. S. Mor
Plant-derived human acetylcholinesterase-R provides protection from lethal organophosphate poisoning and its chronic aftermath
FASEB J, September 1, 2007; 21(11): 2961 - 2969.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y.-J. Huang, Y. Huang, H. Baldassarre, B. Wang, A. Lazaris, M. Leduc, A. S. Bilodeau, A. Bellemare, M. Cote, P. Herskovits, et al.
Recombinant human butyrylcholinesterase from milk of transgenic animals to protect against organophosphate poisoning
PNAS, August 21, 2007; 104(34): 13603 - 13608.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
O. Cohen, C. Kronman, L. Raveh, O. Mazor, A. Ordentlich, and A. Shafferman
Comparison of Polyethylene Glycol-Conjugated Recombinant Human Acetylcholinesterase and Serum Human Butyrylcholinesterase as Bioscavengers of Organophosphate Compounds
Mol. Pharmacol., September 1, 2006; 70(3): 1121 - 1131.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
Y. Gao, E. Atanasova, N. Sui, J. D. Pancook, J. D. Watkins, and S. Brimijoin
Gene Transfer of Cocaine Hydrolase Suppresses Cardiovascular Responses to Cocaine in Rats
Mol. Pharmacol., January 1, 2005; 67(1): 204 - 211.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
H. Sun, M. L. Shen, Y.-P. Pang, O. Lockridge, and S. Brimijoin
Cocaine Metabolism Accelerated by a Re-Engineered Human Butyrylcholinesterase
J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 710 - 716.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
E. G. Duysen, C. F. Bartels, and O. Lockridge
Wild-Type and A328W Mutant Human Butyrylcholinesterase Tetramers Expressed in Chinese Hamster Ovary Cells Have a 16-Hour Half-Life in the Circulation and Protect Mice from Cocaine Toxicity
J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 751 - 758.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
L. Koetzner and J. H. Woods
Characterization of Equine Butyrylcholinesterase Disposition in the Mouse
Drug Metab. Dispos., June 1, 2002; 30(6): 724 - 730.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Bourne, P. Taylor, P. E. Bougis, and P. Marchot
Crystal Structure of Mouse Acetylcholinesterase. A PERIPHERAL SITE-OCCLUDING LOOP IN A TETRAMERIC ASSEMBLY
J. Biol. Chem., January 29, 1999; 274(5): 2963 - 2970.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Kronman, T. Chitlaru, E. Elhanany, B. Velan, and A. Shafferman
Hierarchy of Post-translational Modifications Involved in the Circulatory Longevity of Glycoproteins. DEMONSTRATION OF CONCERTED CONTRIBUTIONS OF GLYCAN SIALYLATION AND SUBUNIT ASSEMBLY TO THE PHARMACOKINETIC BEHAVIOR OF BOVINE ACETYLCHOLINESTERASE
J. Biol. Chem., September 15, 2000; 275(38): 29488 - 29502.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics